Value of maximal and submaximal variables during incremental cardiopulmonary exercise testing to predict survival in pateints with pulmonary arterial hypertension (PAH)

E. V.M. Ferreira, J. S.O. Arakaki, P. B. B. Figueiredo, D. Bravo, L. D. Batista, L. E. Nery, J. A. Neder (Sao Paulo, Brazil)

Source: Annual Congress 2009 - Pulmonary circulation I
Session: Pulmonary circulation I
Session type: Thematic Poster Session
Number: 3903
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. V.M. Ferreira, J. S.O. Arakaki, P. B. B. Figueiredo, D. Bravo, L. D. Batista, L. E. Nery, J. A. Neder (Sao Paulo, Brazil). Value of maximal and submaximal variables during incremental cardiopulmonary exercise testing to predict survival in pateints with pulmonary arterial hypertension (PAH). Eur Respir J 2009; 34: Suppl. 53, 3903

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension
Source: Eur Respir J 2012; 40: 1410-1419
Year: 2012



Predictive value of combined metabolic and cardiopulmonary responses to estimate maximal aerobic impairment in patients with pulmonary arterial hypertension
Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy
Year: 2010

Maximal cardiopulmonary exercise testing in mildly symptomatic patients with idiopathic pulmonary arterial hypertension: correlations with 6-min walk distance and resting hemodynamics
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009

The value of cardiopulmonary exercise test in assessment of the severity of pulmonary arterial hypertension patients
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017

Cardiopulmonary exercise test unveils abnormal exercise physiology in patients affected by pulmonary arterial hypertension with a low-risk profile 6 minute walk distance.
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020


Maximal cardiopulmonary exercise testing in children with pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008


Contrasting dynamic cardiopulmonary responses to incremental cycle ergometer exercise testing in patients with COPD and pulmonary hypertension
Source: Annual Congress 2008 - Exercise intolerance: mechanism, intervention and assessment
Year: 2008


Mean pulmonary artery pressure-heart rate (mPAP-HR) relationship during submaximal supine exercise in idiopathic pulmonary arterial hypertension (iPAH)
Source: Annual Congress 2005 - Exercise in pulmonary hypertension
Year: 2005


Effect of treatment on exercise endurance tolerance and ventilatory efficiency in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2011 - Treatment of human pulmonary hypertension
Year: 2011

The sPAP/VO2 ratio during cardiopulmonary exercise testing as predictor of manifest pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012

Contrasting cardiopulmonary responses to incremental exercise in patients with schistosomiasis-associated and idiopathic pulmonary arterial hypertension with similar resting hemodynamic impairment
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011

Comparison of three walking tests to cardiopulmonary exercise tests in the assessment of exercise tolerance in individuals with pulmonary arterial hypertension
Source: International Congress 2016 – Physiotherapy interventions and assessment options in hospitalised patients
Year: 2016

Hemodynamics as a substitute for exercise capacity endpoints in patients with pulmonary arterial hypertension (PAH): A model based assessment for sildenafil
Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension
Year: 2010

Physiological response to the six-minute walk test in pulmonary arterial hypertension
Source: Eur Respir J 2005; 26: 667-672
Year: 2005



Cardiopulmonary exercise testing, six minute walk and hemodynamics in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008


Safety related to maximal cardiopulmonary exercise testing in patients with pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016


The role of cardiopulmonary exercise tests in pulmonary arterial hypertension
Source: Eur Respir Rev, 27 (148) 170134; 10.1183/16000617.0134-2017
Year: 2018



Pulmonary haemodynamics during recovery from maximum incremental cycling exercise
Source: Eur Respir J 2016; 48: 158-167
Year: 2016



Effects of continuous vs. interval aerobic training on PetCO2 response during graded exercise test in patients with coronary artery disease
Source: Annual Congress 2011 - Exercise assessment in different diseases
Year: 2011

Estimation of the exercise ventilatory compensation point by the analysis of the relationship between minute ventilation and heart rate in patients with pulmonary hypertension
Source: Annual Congress 2012 - Limiting factors in exercise
Year: 2012